THC

Thinking of Buying Tenet Healthcare (THC)? Here's What You Need to Know.

Shares of Health Care sector company Tenet Healthcare moved 0.7% today, and are now trading at a price of $82.21. The mid-cap stock's daily volume was 28,644 compared to its average volume of 1,425,022. The S&P 500 index returned a 1.0% performance.

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company is based in Dallas and has 75,776 full time employees. Its market capitalization is $8,380,076,032.

The only analyst following Tenet Healthcare has set a target price of $0.2 per share, which is 41005.0 away from its current price. This analyst rates the stock as buy.

Over the last year, THC's share price has increased by 4843.6%, which represents a difference of 3351.0% when compared to the S&P 500. The stock's 52 week high is $85.4 per share whereas its 52 week low is $36.69. Tenet Healthcare's average free cash flow over the last 4 years has been $1.17 Billion, but they have been decreasing at an average rate of -13.1%. This may prove a challenge to the long term sustainability of the stock's upwards trend.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cashflow ($ k) YoY Growth (%)
2022-12-31 1,083,000 -762,000 321,000 -64.73
2021-12-31 1,568,000 -658,000 910,000 -68.26
2020-12-31 3,407,000 -540,000 2,867,000 409.24
2019-12-31 1,233,000 -670,000 563,000 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS